multiple sclerosis therapeutic (LIFNano Therapeutics)

N/A

Report date: 2025/03/20 14:56:06

Base Information

Drug Namemultiple sclerosis therapeutic (LIFNano Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLeukemia inhibitory factor receptor antagonists
TargetsLeukemia inhibitory factor receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLIFNano Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLIFNano Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A